Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND & AIMS: Obesity-associated inflammation is a key player in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). However, the role of macrophage scavenger receptor 1 (MSR1, CD204) remains incompletely understood. METHODS: and wild-type mice were subjected to a 16-week high-fat and high-cholesterol diet. Mice and ex vivo human liver slices were treated with a monoclonal antibody against MSR1. Genetic susceptibility was assessed using genome-wide association study data from 1,483 patients with NAFLD and 430,101 participants of the UK Biobank. RESULTS: MSR1 expression was associated with the occurrence of hepatic lipid-laden foamy macrophages and correlated with the degree of steatosis and steatohepatitis in patients with NAFLD. Mice lacking Msr1 were protected against diet-induced metabolic disorder, showing fewer hepatic foamy macrophages, less hepatic inflammation, improved dyslipidaemia and glucose tolerance, and altered hepatic lipid metabolism. Upon induction by saturated fatty acids, MSR1 induced a pro-inflammatory response via the JNK signalling pathway. In vitro blockade of the receptor prevented the accumulation of lipids in primary macrophages which inhibited the switch towards a pro-inflammatory phenotype and the release of cytokines such as TNF-ɑ. Targeting MSR1 using monoclonal antibody therapy in an obesity-associated NAFLD mouse model and human liver slices resulted in the prevention of foamy macrophage formation and inflammation. Moreover, we identified that rs41505344, a polymorphism in the upstream transcriptional region of MSR1, was associated with altered serum triglycerides and aspartate aminotransferase levels in a cohort of over 400,000 patients. CONCLUSIONS: Taken together, our data suggest that MSR1 plays a critical role in lipid-induced inflammation and could thus be a potential therapeutic target for the treatment of NAFLD. LAY SUMMARY: Non-alcoholic fatty liver disease (NAFLD) is a chronic disease primarily caused by excessive consumption of fat and sugar combined with a lack of exercise or a sedentary lifestyle. Herein, we show that the macrophage scavenger receptor MSR1, an innate immune receptor, mediates lipid uptake and accumulation in Kupffer cells, resulting in liver inflammation and thereby promoting the progression of NAFLD in humans and mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784 · cited 2×
“Growing evidence supports the view that Kupffer cells, the endogenous hepatic macrophages, are initiators of inflammation and hence contribute to NAFLD development, while recruited monocyte-derived macrophages play a crucial role in the disease progression (4-6).”
BackgroundFrom NASH to HCC: current concepts and future challenges
Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0145-7 · Cited by 1,392
Self-citationThe role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Kazankov, K., Jørgensen, S. M. D., Thomsen, K. L., Møller, H. J., Vilstrup, H., George, J., Schuppan, D., & Grønbæk, H. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0082-x · Cited by 941 · cited 4×
“We then excluded individuals with (1) excessive relatives (more than 10 putative third-degree relatives); (2) a mismatch between the self-reported and genetically inferred gender; or (3) putative sex chromosome aneuploidy and (4) those identified by the UK Biobank as outliers based on heterozygosity and missingness (1…”
BackgroundMethodInfluentialNonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
Tiniakos, D. G., Vos, M. B., & Brunt, E. M. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102132 · Cited by 870 · cited 1×
“…not all patients progress from NAFL to NASH and although gene signatures of more advanced fi brosing-steatohepatitis have been identi fi ed, the exact pathogenic pathways involved in the initiating phases of the disease, especially the transition from NAFL to NASH, are not fully understood.”
Self-citationA Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
Francque, S. M., Bedossa, P., Ratziu, V., Anstee, Q. M., Bugianesi, E., Sanyal, A. J., Loomba, R., Harrison, S. A., Balabanska, R., Mateva, L., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2036205 · Cited by 801
Self-citationCawthorn, W. P., & Sethi, J. K. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.051 · Cited by 791
Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
Montagner, A., Polizzi, A., Fouché, E., Ducheix, S., Lippi, Y., Lasserre, F., Barquissau, V., Régnier, M., Lukowicz, C., Benhamed, F., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310798 · Cited by 736
Krenkel, O., Puengel, T., Govaere, O., Abdallah, A. T., Mossanen, J. C., Kohlhepp, M., Liepelt, A., Lefebvre, E., Luedde, T., Hellerbrand, C., et al. (2018) · Hepatology · doi:10.1002/hep.29544 · Cited by 557 · cited 1×
“125 Growing evidence supports the view that Kupffer cells, the endogenous hepatic macrophages, 126 are initiators of inflammation and hence contribute to NAFLD development, whilst recruited 127 monocyte-derived macrophages play a crucial role in the disease progression (4, 5).”
BackgroundSelf-citationHepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2
Miura, K., Yang, L., van Rooijen, N., Ohnishi, H., & Seki, E. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00365.2011 · Cited by 503 · cited 1×
“Kupffer cell depletion by clodronate liposomes in mice on a choline-deficient l-amino acid354 defined diet for 22 weeks suppresses the infiltration of inflammatory cells, mainly monocytes, 355 into the liver (31).”
BackgroundAnstee, Q. M., Darlay, R., Cockell, S., Meroni, M., Govaere, O., Tiniakos, D., Burt, A. D., Bedossa, P., Palmer, J., Liu, Y.-L., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.003 · Cited by 499
Self-citationGovaere, O., Cockell, S., Tiniakos, D., Queen, R., Younes, R., Vacca, M., Alexander, L., Ravaioli, F., Palmer, J., Petta, S., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aba4448 · Cited by 479 · cited 1×
“identified, the exact pathogenic pathways involved in the initiating phases of the disease, 123 especially the transition from NAFL to NASH, are not fully understood (3).”
BackgroundSelf-citationLancaster, G. I., Langley, K. G., Berglund, N. A., Kammoun, H. L., Reibe, S., Estevez, E., Weir, J., Mellett, N. A., Pernes, G., Conway, J. R. W., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.014 · Cited by 466 · cited 1×
“8 Recently, we have shown that in vitro activation of the phagocytic receptor, macrophage scavenger receptor 1 (MSR1, also known as SR-A or CD204), results in pro-in fl ammatory macrophage polarisation through JNK activation.”
BackgroundFrom NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
Gastaldelli, A., & Cusi, K. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.07.002 · Cited by 455 · cited 1×
“333 In a setting of lipid overload, MSR1 deficiency not only led to reduced hepatic inflammation and 334 changes in hepatic lipid metabolism but it also reduced circulating fatty acids, increased lipid 335 storage in the adipose tissue and improved glucose tolerance, highlighting the importance of the 336 liver-adipos…”
BackgroundStienstra, R., Saudale, F., Duval, C., Keshtkar, S., Groener, J. E. M., van Rooijen, N., Staels, B., Kersten, S., & Müller, M. (2010) · Hepatology · doi:10.1002/hep.23337 · Cited by 452 · cited 1×
“…cell depletion has been reported to activate Ppara signalling in hepatocytes while resulting in overall reduced levels of hepatic triglycerides in mice fed a 45%-HFD. 23 Furthermore, hepatocyte-restricted Ppara deletion in mice impaired liver lipid metabolism, leading to increased plasma FFAs.”
Luukkonen, P. K., Sädevirta, S., Zhou, Y., Kayser, B., Ali, A., Ahonen, L., Lallukka, S., Pelloux, V., Gaggini, M., Jian, C., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0071 · Cited by 428 · cited 1×
“2 Growing evidence supports the view that Kupffer cells, the endogenous hepatic macrophages, are initiators of in fl ammation and hence contribute to NAFLD development, whilst recruited monocyte-derived macrophages are often observed in advanced stages of the disease.”
Self-citationBrunt, E. M., Kleiner, D. E., Wilson, L. A., Unalp, A., Behling, C. E., Lavine, J. E., & Neuschwander‐Tetri, B. A. (2009) · Hepatology · doi:10.1002/hep.22724 · Cited by 390
Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors
Francque, S., Szabo, G., Abdelmalek, M. F., Byrne, C. D., Cusi, K., Dufour, J.-F., Roden, M., Sacks, F., & Tacke, F. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00366-5 · Cited by 316 · cited 1×
“Peroxisome proliferator−activated receptors 359 (PPAR) are nuclear receptors playing key roles in metabolic homeostasis and inflammation (32).”
BackgroundSelf-citationSaturated Fatty Acids Induce c-Src Clustering within Membrane Subdomains, Leading to JNK Activation
Holzer, R. G., Park, E.-J., Li, N., Tran, H., Chen, M., Choi, C., Solinas, G., & Karin, M. (2011) · Cell · doi:10.1016/j.cell.2011.08.034 · Cited by 284 · cited 1×
“3 Hepatic macrophages are responsive to a variety of stimuli including bacterial endotoxins (such as lipopolysaccharide) but also free fatty acids (FFAs) or cholesterol.”
Manning-Tobin, J. J., Moore, K. J., Seimon, T. A., Bell, S. A., Sharuk, M., Alvarez-Leite, J. I., de Winther, M. P. J., Tabas, I., & Freeman, M. W. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.176644 · Cited by 266 · cited 1×
“MSR1 is a key macrophage 148 receptor for the clearance of circulating lipoproteins and has been implicated in atherogenesis 149 (16, 17).”
Bieghs, V., Wouters, K., van Gorp, P. J., Gijbels, M. J. J., de Winther, M. P. J., Binder, C. J., Lütjohann, D., Febbraio, M., Moore, K. J., van Bilsen, M., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.02.051 · Cited by 160
CD44 is a key player in non-alcoholic steatohepatitis
Patouraux, S., Rousseau, D., Bonnafous, S., Lebeaupin, C., Luci, C., Canivet, C. M., Schneck, A.-S., Bertola, A., Saint‐Paul, M., Iannelli, A., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.003 · Cited by 147 · cited 1×
“20 This is in line with a previous study reporting that Kupffer cell depletion by clodronate liposomes reduces in fi ltration of in fl ammatory cells, mainly monocytes, into the livers of mice on a 22-week choline-de fi cient l-amino acid-de fi ned diet.”
Hardy, T., Wonders, K., Younes, R., Aithal, G. P., Aller, R., Allison, M., Bedossa, P., Betsou, F., Boursier, J., Brosnan, M. J., et al. (2020) · Contemporary Clinical Trials · doi:10.1016/j.cct.2020.106175 · Cited by 135
Self-citationBeier, K., Völkl, A., & Fahimi, H. D. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00805-3 · Cited by 98 · cited 1×
“26,27 Furthermore, Tnf ɑ affects glucose homeostasis in adipocytes and promotes lipolysis in cultured adipocytes, which could explain the obese phenotype in our Msr1 -/- HFD-fed mice.”
Triggering MSR1 promotes JNK‐mediated inflammation in IL‐4‐activated macrophages
Guo, M., Härtlova, A., Gierliński, M., Prescott, A., Castellvi, J., Losa, J. H., Petersen, S. K., Wenzel, U. A., Dill, B. D., Emmerich, C. H., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2018100299 · Cited by 96 · cited 3×
“Triggering of Msr1 has recently been shown to induce JNK signaling pathway activation (8).”
BackgroundMethodSelf-citationGovaere, O., Cockell, S., Van Haele, M., Wouters, J., Van Delm, W., Van den Eynde, K., Bianchi, A., van Eijsden, R., Van Steenbergen, W., Monbaliu, D., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5228 · Cited by 61
Self-citationTNFα sensitizes hepatocytes to FasL-induced apoptosis by NFκB-mediated Fas upregulation
Faletti, L. E., Peintner, L., Neumann, S., Sandler, S., Grabinger, T., Nelly, S. M., Merfort, I., Huang, C., Tschaharganeh, D. F., Kang, T.-W., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0935-9 · Cited by 61 · cited 1×
“26,27 Furthermore, Tnf ɑ affects glucose homeostasis in adipocytes and promotes lipolysis in cultured adipocytes, which could explain the obese phenotype in our Msr1 -/- HFD-fed mice.”
RNA sequencing and transcriptomal analysis of human monocyte to macrophage differentiation
Dong, C., Zhao, G., Zhong, M., Yue, Y., Wu, L. J., & Xiong, S. (2013) · Gene · doi:10.1016/j.gene.2013.02.015 · Cited by 54 · cited 3×
“To unravel transcriptional regulatory mechanisms of MSR1, we used publicly 316 available RNA sequencing data comparing human monocytes with differentiated macrophages, 317 which identified 1,208 differentially expressed genes, with MSR1 mRNA expression increased in 318 the macrophage population (24).”
BackgroundMethodInfluential
Cited by
Peiseler, M., Schwabe, R., Hampe, J., Kubes, P., Heikenwälder, M., & Tacke, F. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.012 · Cited by 564
Metabolic reprogramming in liver fibrosis
Horn, P., & Tacke, F. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.05.003 · Cited by 432
Metabolic regulation of the immune system in health and diseases: mechanisms and interventions
Hu, T., Liu, C.-H., Lei, M., Zeng, Q., Li, L., Tang, H., & Zhang, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01954-6 · Cited by 383
The Multifaceted Roles of Macrophages in NAFLD Pathogenesis
Vonderlin, J., Chavakis, T., Sieweke, M., & Tacke, F. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.03.002 · Cited by 96
Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver Disease
Wiering, L., Subramanian, P., & Hammerich, L. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.02.010 · Cited by 80
Metadata
- Authors
- Govaere, O., Petersen, S. K., Martinez-Lopez, N., Wouters, J., Van Haele, M., Mancina, R. M., Jamialahmadi, O., Bilkei-Gorzo, O., Lassen, P. B., Darlay, R., Peltier, J., Palmer, J. M., Younes, R., Tiniakos, D., Aithal, G. P., Allison, M., Vacca, M., Göransson, M., Berlinguer-Palmini, R., Clark, J. E., Drinnan, M. J., Yki-Järvinen, H., Dufour, J.-F., Ekstedt, M., Francque, S., Petta, S., Bugianesi, E., Schattenberg, J. M., Day, C. P., Cordell, H. J., Topal, B., Clément, K., Romeo, S., Ratziu, V., Roskams, T., Daly, A. K., Anstee, Q. M., Trost, M., & Härtlova, A.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2022-05
- Volume
- 76
- Issue
- 5
- Pages
- 1001-1012
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W4226120218
- Cited by
- 165
- References
- 28
- FWCI
- 13.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.